Latest News Feeds
Office of Health Economics (OHE) -
Why might the launch price of a new drug be a poor indicator of future expenditure for a drug? Which are the factors that determine the future prices and market shares of a drug? Understanding the answers to these questions can be crucial when conducting cost-effectiveness analyses i.e. when studying if it is desirable to publicly fund reimburse a new drug. This paper models and studies the price of a new drug along its life-cycle, from launch to discontinuation, to understand how the price of the drug evolves and to help inform cost-effectiveness evaluations.
Please note this item requires free registration for full-text access.
This three year project aimed to investigate how commissioners negotiated, specified, monitored and managed contractual mechanisms to improve services and allocate financial risk in their local health economies, looking at both acute services and community health care.
Public Health England (PHE) -
This annual plan sets out how Public Health England will deliver its core functions, outlining actions it will be the taking over the next year to protect and improve the public’s health and reduce inequalities.
Care and communication between health professionals and patients affected by severe or chronic illness in community care settings: a qualitative study of care at the end of life
National Institute for Health Research (NIHR) -
Advance care planning (ACP) enables patients to consider, discuss and, if they wish, document their wishes and preferences for future care, including decisions to refuse treatment, in the event that they lose capacity to make decisions for themselves. This study aimed to investigate how patients, their relatives and health professionals initiate and experience discussion of ACP and the outcomes of advance discussions in shaping care at the end of life.
NHS England -
This guidance outlines the initial support package for the new models of care vanguards. The support package focuses on eight key areas: designing new care models; evaluation and metrics; integrated commissioning and provision; empowering patients and communities; harnessing technology; workforce redesign; local leadership and delivery; and communications and engagement.
General Medical Council (GMC) -
This new single set of standards cover both undergraduate and postgraduate medical education and are designed to put patient safety, quality of care, and fairness at the heart of the training received by both medical students and doctors. It also makes the roles and responsibilities of organisations delivering medical education clearer as well as the requirements for teaching, supervision and support. This standard replaces current GMC standards set out in Tomorrow's Doctors (aimed at medical students) and The Trainee Doctor (aimed at postgraduate doctors in training) and comes into effect on 1st January 2016.
Department of Health (DH) -
This consultation seeks feedback on a proposal which aims to reduce the size of the General Osteopathic Council's governing council, by making amendments to The General Osteopathic Council (Constitution) Order 2009. They are seeking to reduce their board from 14 to 10 members, following steps taken by a number of other councils to gain benefits from having a smaller, more strategic board. This consultation closes on 25 September 2015.